LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The financial performance was robust with significant year-over-year increases in revenue, gross margin, operating income, net income, and EPS. The company also demonstrated strong cash flow from operations. These positive results, coupled with the market cap of a small-cap stock, suggest a strong positive stock price reaction over the next two weeks.
Key Financial Performance
Revenue Revenue for Q1 2026 was $45.2 million, representing a 12% increase year-over-year. The growth was driven by strong sales in North America and Europe, as well as the successful launch of new products.
Gross Margin Gross margin improved to 68.5%, up from 66.2% in Q1 2025. This 2.3 percentage point increase was attributed to better product mix and operational efficiencies.
Operating Income Operating income rose to $12.8 million, a 15% increase compared to Q1 2025. The improvement was due to higher revenue and controlled operating expenses.
Net Income Net income for the quarter was $9.6 million, up 18% year-over-year. This increase was primarily due to higher operating income and lower interest expenses.
Earnings Per Share (EPS) Earnings per share (EPS) grew to $0.48, a 20% increase from $0.40 in Q1 2025. The growth was driven by improved net income.
Cash Flow from Operations Cash flow from operations was $10.2 million, up 25% year-over-year, supported by strong earnings and effective working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
CEO Roberts
Cautionary Statement
Chief Financial
Director PM
Division Nathan
Division Sidoti
Division Welcome
EDT Petusky
Factors SEC
Financial Officer
Frank Takkinen
George LeMaitre
LLC Frank
Lake Street
LeMaitre Chairman
LeMaitre Vascular
Markets LLC
Nathan Treybeck
Officer George
Officer LeMaitre
PM EDT
Reconciliations measure
Risk Factors
Sidoti LLC
Statement information
Street Capital
Treybeck Wells
date Cautionary
estimate
information Risk
sale Reconciliations
sir harbor
statement
LMAT Transcript
LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript
Positive5-6
The financial performance was robust with significant year-over-year increases in revenue, gross margin, operating income, net income, and EPS. The company also demonstrated strong cash flow from operations. These positive results, coupled with the market cap of a small-cap stock, suggest a strong positive stock price reaction over the next two weeks.
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call summary indicates strong financial performance with a 20% YoY revenue increase and a transition to net income from a loss. The optimistic guidance for operating income growth and EPS, along with strategic initiatives like sales force expansion and new distribution centers, contribute to a positive outlook. However, the absence of discussions on shareholder returns and potential risks tempers the sentiment slightly. Given the market cap, the stock is likely to see a positive movement (2% to 8%) over the next two weeks.
LeMaitre Vascular, Inc. (LMAT) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call summary indicates strong financial performance with a 10% YoY revenue increase, improved margins, and positive net income growth. Strategic initiatives for market expansion and product innovation, along with optimistic revenue and margin projections for 2026, further enhance the outlook. Despite some regulatory risks, the overall sentiment is positive, supported by robust financial metrics and strategic plans. The market cap suggests moderate stock price sensitivity, leading to a positive prediction.
LeMaitre Vascular, Inc. (LMAT) Q3 2025 Earnings Call Transcript
Positive11-7
The company has raised its full-year revenue guidance and EPS, indicating strong financial performance. Despite some management ambiguity on future metrics, the overall sentiment is positive with strategic growth plans, including Artegraft and XenoSure expansion, and a robust sales force strategy. The market cap suggests moderate reaction, predicting a 2-8% stock price increase.
LMAT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
